✦ LIBER ✦

Successful treatment of a patient with lymphocyte-predominant Hodgkin’s lymphoma with yttrium-90-ibritumomab tiuxetan

✍ Scribed by Niklas Zojer; Siroos Mirzaei; Heinz Ludwig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ongoing Trials with Yttrium 90–Labeled I

✍ Micallef, Ivana N.M. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 366 KB

Radioisotopic Localization of90Yttrium–I

✍ S. A. Jacobs; A. M. Harrison; S. H. Swerdlow; K. A. Foon; N. Avril; N. Vidnovic; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 589 KB

Safety and Efficacy of Yttrium-90 Ibritu

✍ Emmanouilides, Christos; Witzig, Thomas E.; Wiseman, Gregory A.; Gordon, Leo I.; 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 149 KB

Efficacy and safety of yttrium-90 ibritu

✍ Makoto Nakagawa, Naokuni Uike, Ilseung Choi… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 211 KB

Factors Associated with Toxicity and Res

✍ Borghaei, Hossein; Wallace, Stephen G.; Schilder, Russell J. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 113 KB

Treatment with yttrium 90 ibritumomab ti

✍ Emmanouilides, Christos; Witzig, Thomas E.; Gordon, Leo I.; Vo, Katie; Wiseman, 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 352 KB